Paige OmniScreen™ is an advanced AI application designed to detect phenotypic changes associated with genetic alterations in cancer. Developed using Virchow and trained on next-generation sequencing assay data, OmniScreen recognizes key mutations and pathways critical to cancer progression.

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that...

Introducing Paige Prostate, the first AI-based pathology product to receive FDA marketing authorization for in vitro diagnostic (IVD) use in detecting cancer in prostate needle biopsies.

Paige’s AI solutions are designed to equip healthcare professionals with the tools they need to navigate the complexities of cancer and deliver personalized, informed care. Clinical tissue-based AI applications developed to assist pathologists in the identification and classification of cancer.

Aug 12, 2024 · In September, Paige tapped Microsoft to construct what it called the "world’s largest” AI model built upon countless images of cancer biopsies. The updated versions of...

Paige was the first company to secure FDA clearance for an AI application in pathology, redefining what’s possible in cancer diagnostics. Our foundation models—trained on millions of slides from diverse populations—set a new standard for …

Mar 14, 2025 · A new digital health start up Paige.AI has been launched this week, promising to revolutionise clinical diagnosis and cancer treatment through use of artificial intelligence (AI).

Mar 14, 2025 · Paige GI Suite is the latest in Paige’s portfolio of AI-driven pathology solutions, furthering the company’s mission to advance precision medicine and pathology innovation. All of Paige’s AI-assisted diagnostic applications including the new GI Suite, are available within Paige Alba™, the Paige Platform, and our partnership digital ...

Aug 23, 2024 · Paige, a leader in next-generation AI technology, announces the launch of OmniScreen, a pioneering AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 molecular biomarkers from routine H&E-stained digital pathology slides.

Mar 13, 2025 · Unlike other AI solutions that focus on a single tissue type, the Paige GI Suite* is a comprehensive, system-wide solution, enabling AI-assisted analysis of biopsies from any region of the GI ...